Marcello Fabio Maida

Istruzione/Formazione

25/05/2015
Laurea specialistica (4-5 anni) - Specializzazione in Gastroenterologia
presso: Facoltà di Medicina Università degli Studi di Palermo
votazione: 50

26/03/2009
Laurea specialistica (4-5 anni) - Laurea magistrale in Medicina e Chirurgia
presso: Facoltà di Medicina Università degli Studi di Palermo
votazione: 110

Pubblicazioni

Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection.
Petta S, Cammà C, Di Marco V, Macaluso FS, Maida M, Pizzolanti G, Belmonte B, Cabibi D, Di Stefano R, Ferraro D, Guarnotta C, Venezia G, Craxì A. Liver Int. 2011 Apr;31(4):507-15.

Multifocal pyoderma gangrenosum resistant to infliximab in active ulcerative colitis: Don't forget the role of cyclosporin.
Sinagra E, Orlando A, Renna S, Maida M, Cottone M. Inflamm Bowel Dis. 2011 Oct 29.

Causes of and prevention strategies for hepatocellular carcinoma.
Cabibbo G, Maida M, Genco C, Antonucci M, Cammà C. Semin Oncol. 2012 Aug;39(4):374-83.

Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study
Cabibbo G, Maida M, Genco C, Parisi P, Peralta P, Antonucci M, Brancatelli G, Cammà C, Craxì A, Di Marco V World J Hepatol 2012 September 27; 4(9): 256-261.

Treatment of hepatocellular carcinoma: present and future.
Genco C, Cabibbo G, Maida M, Brancatelli G, Galia M, Alessi N, Butera G, Genova C, Romano P, Raineri M, Giarratano A, Midiri M, Cammà C. Expert Rev Anticancer Ther. 2013 Apr;13(4):469-79.

Primary biliary cirrhosis and hereditary hemorrhagic telangiectasia: When two rare diseases coexist.
Macaluso FS, Maida M, Alessi N, Cabibbo G, Cabibi D. World J Hepatol. 2013 May 27;5(5):288-91.

Assessment of treatment response in hepatocellular carcinoma: a review of the literature.
Maida M, Cabibbo G, Brancatelli G, Genco C, Alessi N, Genova C, Romano P, Raineri M, Giarratano A, Midiri M, Cammà C. Future Oncol. 2013 Jun;9(6):845-54.

Progressive multi-organ expression of immunoglobulin G4-related disease: A case report.
Maida M, Macaluso FS, Cabibbo G, Lo Re G, Alessi N. World J Hepatol. 2013 Jun 27;5(6):336-9.

Hepatobiliary and Pancreatic: Portal hypertensive biliopathy presenting as acute cholangitis.
Macaluso F, Maida M, Burgio MD, Brancatelli G. J Gastroenterol Hepatol. 2013 Aug;28(8):1257.

Survival of Patients with Hepatocellular Carcinoma (HCC) Treated by Percutaneous Radio-Frequency Ablation (RFA) Is Affected by Complete Radiological Response.
Cabibbo G, Maida M, Genco C, Alessi N, Peralta M, Butera G, Galia M, Brancatelli G, Genova C, Raineri M, Orlando E, Attardo S, Giarratano A, Midiri M, Di Marco V, Craxì A, Cammà C. PLoS One. 2013 Jul 29;8(7):e70016. doi: 10.1371/journal.pone.0070016. Print 2013.

Metabolic Factors and Chronic Hepatitis C: A Complex Interplay.
Macaluso FS, Maida M, Minissale MG, Li Vigni T, Attardo S, Orlaldo E, Petta S. BioMed Research International 2013 http://dx.doi.org/10.1155/2013/564645.

Imaging appearance of treated hepatocellular carcinoma.
Agnello F, Salvaggio G, Cabibbo G, Maida M, Lagalla R, Midiri M, Brancatelli G. World J Hepatol. 2013 Aug 27;5(8):417-24. doi: 10.4254/wjh.v5.i8.417.

Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients with Chronic HCV Genotype 1 Infection.
Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients with Chronic HCV Genotype 1 Infection. Macaluso FS, Maida M, Cammà C, Cabibi D, Alessi N, Cabibbo G, Di Marco V, Craxì A, Petta S. Clin Gastroenterol Hepatol. 2013 Oct 7. pii: S1542-3565(13)01507-3.

Is the efficacy of sorafenib treatment in patients with hepatocellular carcinoma affected by age?
Cabibbo G, Maida M, Cammà C, Craxì A. Expert Rev Anticancer Ther. 2013 Dec;13(12):1355-61. doi: 10.1586/14737140.2013.859989. Epub 2013 Nov 13.

Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study.
Licata A, Maida M, Bonaccorso A, Macaluso FS, Cappello M, Craxì A, Almasio PL. World J Hepatol. 2013 Dec 27;5(12):685-91. doi: 10.4254/wjh.v5.i12.685.

Hepatocellular carcinoma and synchronous liver metastases from colorectal cancer in cirrhosis: A case report.
Maida M, Macaluso FS, Galia M, Cabibbo G. World J Hepatol. 2013 Dec 27;5(12):696-700. doi: 10.4254/wjh.v5.i12.696.

Staging systems of hepatocellular carcinoma: A review of literature.
Maida M, Orlando E, Cammà C, Cabibbo G. World J Gastroenterol. 2014 Apr 21;20(15):4141-4150.

Steatosis Affects the Performance of Liver Stiffness Measurement for Fibrosis Assessment in Patients with Genotype 1 Chronic Hepatitis C.
Macaluso FS, Maida M, Cammà C, Cabibbo G, Cabibi D, Alduino R, Marco VD, Craxì A, Petta S. J Hepatol. 2014 Sep;61(3):523-9. doi: 10.1016/j.jhep.2014.04.045. Epub 2014 May 9.

Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: A retrospective cohort study.
Licata A, Maida M, Cabibi D, Butera G, Macaluso FS, Alessi N, Caruso C, Craxì A, Almasio PL.Dig Liver Dis. 2014 Sep 12. pii: S1590-8658(14)00660-4. doi: 10.1016/j.dld.2014.08.040.

Predictors of survival of patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib.
Iavarone M, Cabibbo G, Biolato M, Corte CD, Maida M, Barbàra M, Basso M, Vavassori S, Craxì A, Grieco A, Cammà C, Colombo M. Hepatology. 2015 Feb 2. doi: 10.1002/hep.27729.

The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease.
Petta S, Maida M, Macaluso FS, Marco VD, Cammà C, Cabibi D, Craxì A. Hepatology. 2015 Apr 9. doi: 10.1002/hep.27844. [Epub ahead of print].

TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C.
Petta S, Maida M, Grimaudo S, Pipitone RM, Macaluso FS, Cabibi D, Cammà C, Di Marco V, Sferrazza S, Craxì A. Liver Int. 2015 Jul 17. doi: 10.1111/liv.12918. [Epub ahead of print]

Second line systemic therapies for hepatocellular carcinoma: Reasons for the failure.
Maida M, Iavarone M, Raineri M, Cammà C, Cabibbo G. World J Hepatol. 2015 Aug 18;7(17):2053-7. doi: 10.4254/wjh.v7.i17.2053.

Hepatitis C Virus Infection is Associated With Increased Cardiovascular Mortality: A Meta-analysis of Observational Studies.
Petta S, Maida M, Macaluso FS, Barbara M, Licata A, Craxì A, Cammà C. Gastroenterology. 2015 Sep 16. pii: S0016-5085(15)01322-0. doi: 10.1053/j.gastro.2015.09.007.

Sorafenib for Hepatocellular Carcinoma: From Randomized Controlled Trials to Clinical Practice.
Cabibbo G, Petta S, Maida M, Cammà C. Dig Dis. 2015 Sep;33(5):668-74. doi: 10.1159/000438477.

Genetic background in nonalcoholic fatty liver disease: A comprehensive review.
Macaluso FS, Maida M, Petta S. World J Gastroenterol. 2015 Oct 21;21(39):11088-111.

Refining prognosis after trans-arterial chemo-embolization for hepatocellular carcinoma.
Cappelli A, Cucchetti A, Cabibbo G, Mosconi C, Maida M, Attardo S, Pettinari I, Pinna AD, Golfieri R. Liver Int. 2015 Nov 25. doi: 10.1111/liv.13029.

Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.
Bucci L, Garuti F, Camelli V, Lenzi B, Farinati F, Giannini EG, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Sacco R, Maida M, Felder M, Morisco F, Gasbarrini A, Gemini S, Foschi FG, Missale G, Masotto A, Affronti A, Bernardi M, Trevisani F; Italian Liver Cancer (ITA.LI.CA) Group; Italian Liver Cancer ITA LI CA Group. Aliment Pharmacol Ther. 2015 Dec 14. doi: 10.1111/apt.13485.

Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis.
Cabibi D, Bronte F, Porcasi R, Ingrao S, Giannone AG, Maida M, Grazia Bavetta M, Petta S, Di Marco V, Calvaruso V. Anal Cell Pathol (Amst). 2015;2015:431750. doi: 10.1155/2015/431750. Epub 2015 Nov 17.

Years of life that could be saved from prevention of hepatocellular carcinoma.
Cucchetti A, Trevisani F, Bucci L, Ravaioli M, Farinati F, Giannini EG, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Sacco R, Maida M, Felder M, Morisco F, Gasbarrini A, Gemini S, Foschi FG, Missale G, Masotto A, Affronti A, Bernardi M, Pinna AD; Italian Liver Cancer (ITA.LI.CA) group; Italian Liver Cancer ITA LI CA group. Aliment Pharmacol Ther. 2016 Apr;43(7):814-24. doi: 10.1111/apt.13554. Epub 2016 Feb 11.

Complete and Sustained Off-Therapy Response to Sorafenib in Advanced Hepatocellular Carcinoma.
Maida M, Macaluso FS, Valenza F, Virdone R. J Gastrointestin Liver Dis. 2016 Jun;25(2):253-5.

Letter: a prospective real life comparison of the efficacy of adalimumab vs. golimumab in moderate to severe ulcerative colitis.
Renna S, Orlando E, Macaluso FS, Maida M, Affronti M, Giunta M, Sapienza C, Rizzuto G, Orlando R, Dimarco M, Cottone M, Orlando A. Aliment Pharmacol Ther. 2016 Aug;44(3):310-1.

Non-invasive assessment of liver injury in non-alcoholic fatty liver disease: a review of literature.
Maida M, Macaluso FS, Salomone F, Petta S. Curr Mol Med. 2016 Oct 4. [Epub ahead of print]

Screening and surveillance for hepatocellular carcinoma: perspective of a new era?
Maida M, Malizia G, Affronti A, Virdone R, Maida C, Margherita V, D'Amico G. Expert Rev Anticancer Ther. 2016 Oct 12. [Epub ahead of print]

Clinical Course and Genetic Susceptibility of Primary Biliary Cirrhosis: Analysis of a Prospective Cohort.
Almasio PL, Licata A, Maida M, Macaluso FS, Costantino A, Alessi N, Grimaudi S, Accardi G, Caruso and Craxì A. Hepat Mon. 2016 Oct 16. [Epub ahead of print]

Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-α inhibitors and conventional immunosuppressants.
Macaluso FS, Maida M, Renna S, Orlando E, Affronti M, Sapienza C, Dimarco M, Orlando R, Rizzuto G, Cottone M, Orlando A. Dig Liver Dis. 2016 Oct 14. pii: S1590-8658(16)30747-2. doi: 10.1016/j.dld.2016.10.001.